Core Viewpoint - Tianyu Semiconductor (02658) has signed a strategic cooperation agreement with South Korean semiconductor manufacturer EYEQ Lab, which is expected to enhance its market position in the global semiconductor industry [1] Group 1: Company Developments - Tianyu Semiconductor's stock price increased by over 11% in early trading, reaching a price of 54.1 HKD with a trading volume of 13.57 million HKD [1] - The agreement with EYEQ Lab involves the supply of high-quality SiC (Silicon Carbide) epitaxial wafers, covering specifications from 6 to 8 inches and voltage ratings from 650V to 20,000V [1] - The strategic partnership is set to last for three years, with EYEQ Lab prioritizing the procurement of SiC wafers from Tianyu Semiconductor under equal conditions [1] Group 2: Industry Implications - The collaboration aims to leverage Tianyu Semiconductor's capabilities in SiC epitaxial wafers and EYEQ Lab's expertise in SiC power device design and manufacturing [1] - This partnership is expected to create a long-term stable supply-demand synergy, accelerating the large-scale commercialization of products [1] - The initiative is designed to expand market opportunities for both companies and strengthen Tianyu Semiconductor's competitive position within the global semiconductor supply chain [1]

Core Viewpoint - The company strongly opposes the Dutch government's intervention in Nexperia's operations, arguing that it politicizes commercial issues and is based on unfounded "national security" claims, which contradicts the principles of market economy and fair competition advocated by the EU [1][2]. Group 1: Company Compliance and Contributions - Since the acquisition of Nexperia, the company has adhered to local laws and regulations, maintaining transparency and good governance, contributing significantly to the European semiconductor industry [2]. - Nexperia has established R&D and manufacturing centers in the Netherlands, Germany, and the UK, employing thousands of workers, and has increased R&D investment by over 150% in the past three years [2]. - The company contributed €130 million in corporate income tax to the Netherlands over the past five years, demonstrating its substantial economic impact [2]. Group 2: Operational Performance Post-Acquisition - Following the complete acquisition of Nexperia, the company's operational quality has significantly improved, with revenue reaching a peak of €2.36 billion in 2022 and gross margin increasing from 25% in 2020 to 42.4% in 2022 [4]. - By October 2024, Nexperia is expected to have paid off all prior debts, achieving a "zero debt" status, while R&D investment is projected to grow from €112 million in 2019 to €284 million in 2024 [4]. - The number of global patent applications has surged, with 110 new applications expected in 2024, compared to an average of 10-15 annually before 2019 [4]. Group 3: Legal Actions and External Pressures - Some foreign management members are attempting to alter Nexperia's ownership structure through legal means, which is closely linked to the Dutch government's directives, representing a political pressure tactic to undermine shareholder rights [5]. - The company condemns these actions as attempts to disrupt its legitimate governance structure under the guise of compliance [5]. Group 4: Commitment to Rights and Industry Collaboration - The company, as a long-term strategic shareholder, is committed to defending its legal rights and has initiated legal and diplomatic actions to demand the Dutch government rescind its erroneous directives and stop systemic discrimination against Chinese enterprises [6]. - The semiconductor industry is viewed as a product of globalization, with its future dependent on collaboration rather than confrontation, advocating for a fair and non-discriminatory business environment [7].